Newsroom Stories

The annual Music at the Intersection festival will be Sept. 9-10 in midtown’s Grand Center Arts District and will pay homage to the 50th anniversary of hip-hop. WashU is a major sponsor, and students can get discounted tickets.

Volcanic eruptions can cause the Pacific Walker Circulation to temporarily weaken, inducing El Niño-like conditions. Human activity is affecting this system, too.

Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at the School of Medicine. Increasing daily aspirin use in such patients could reduce cardiovascular deaths.

For people who have contracted the COVID-19 virus, pain and suffering may continue two years after infection, according to a new study from the School of Medicine and the Veterans Affairs St. Louis Health Care system.

Raven Maragh-Lloyd, an assistant professor of African and African American studies in Arts & Sciences, will serve as co-principal investigator for a $1.7 million grant investigating online influence campaigns.

The Class of 2027 moves onto the South 40 Friday and Saturday, Aug. 18 and 19. The class is the most diverse in university history. The students hail from 50 states and 29 countries; 53% identify as students of color and 21% are Pell Grant-eligible.

In this highly polarized, post-lockdown world, the college transition can seem especially difficult. WashU happiness expert Tim Bono explains how students can set themselves up for success.

A new test for two blood cancers — developed by a team at the School of Medicine — is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.

A study from biologist Elizabeth Mallott in Arts & Sciences highlights a critical development window during which racial differences in the gut microbiome emerge. Early social and environmental exposures can have large and lasting effects on child development and adult health.

The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. The School of Medicine’s Barbara Joy Snider, MD, PhD, answers questions about the drug.